{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:18:47Z","timestamp":1789460327341,"version":"build-2803163510"},"reference-count":127,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.hoc.2014.04.003","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T23:15:14Z","timestamp":1406157314000},"page":"683-701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["The Pathophysiology of Transfusional Iron Overload"],"prefix":"10.1016","volume":"28","author":[{"given":"John B.","family":"Porter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Garbowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2014.04.003_bib1","series-title":"Iron in biochemistry and medicine","first-page":"427","article-title":"The pathology of iron overload","author":"Jacobs","year":"1974"},{"key":"10.1016\/j.hoc.2014.04.003_bib2","series-title":"Iron metabolism in man","author":"Bothwell","year":"1979"},{"key":"10.1016\/j.hoc.2014.04.003_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.nutr.26.061505.111303","article-title":"Regulation of iron metabolism by hepcidin","volume":"26","author":"Nemeth","year":"2006","journal-title":"Annu Rev Nutr"},{"issue":"5","key":"10.1016\/j.hoc.2014.04.003_bib4","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI38499","article-title":"HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice","volume":"119","author":"Mastrogiannaki","year":"2009","journal-title":"J\u00a0Clin Invest"},{"issue":"5704","key":"10.1016\/j.hoc.2014.04.003_bib5","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.hoc.2014.04.003_bib6","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1182\/blood-2005-06-2398","article-title":"Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin","volume":"106","author":"Delaby","year":"2005","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.hoc.2014.04.003_bib7","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1182\/blood-2011-01-258467","article-title":"Hepcidin and iron regulation, 10 years later","volume":"117","author":"Ganz","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10534-008-9187-y","article-title":"Interacting signals in the control of hepcidin expression","volume":"22","author":"Darshan","year":"2009","journal-title":"Biometals"},{"issue":"9","key":"10.1016\/j.hoc.2014.04.003_bib9","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1629","article-title":"High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin","volume":"13","author":"Tanno","year":"2007","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood-2008-12-195503","article-title":"Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells","volume":"114","author":"Tanno","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2014.04.003_bib11","author":"Kautz","year":"2014","journal-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism, Nat Genet"},{"issue":"4","key":"10.1016\/j.hoc.2014.04.003_bib12","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1182\/blood-2005-07-2614","article-title":"Iron metabolism in the hemoglobin-deficit mouse: correlation of diferric transferrin with hepcidin expression","volume":"107","author":"Wilkins","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2014.04.003_bib13","first-page":"14","article-title":"Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein","volume":"14","author":"Nemeth","year":"2002","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2014.04.003_bib14","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1182\/blood-2006-06-028787","article-title":"Suppression of hepcidin during anemia requires erythropoietic activity","volume":"108","author":"Pak","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2014.04.003_bib15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2141.2012.09104.x","article-title":"Stimulated erythropoiesis with secondary iron loading leads to a decrease in hepcidin despite an increase in bone morphogenetic protein 6 expression","volume":"157","author":"Frazer","year":"2012","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.hoc.2014.04.003_bib16","doi-asserted-by":"crossref","first-page":"667","DOI":"10.33549\/physiolres.930841","article-title":"Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis","volume":"55","author":"Vokurka","year":"2006","journal-title":"Physiol Res"},{"issue":"8","key":"10.1016\/j.hoc.2014.04.003_bib17","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1097\/CCM.0b013e31818103b9","article-title":"Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia","volume":"36","author":"Lasocki","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.hoc.2014.04.003_bib18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0092-8674(91)90312-M","article-title":"Structural relationship between an iron-regulated RNA binding protein (IRE-BP) and aconitase: functional implications","volume":"64","author":"Rouault","year":"1991","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.hoc.2014.04.003_bib19","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1182\/blood-2004-12-4703","article-title":"Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2","volume":"106","author":"Cooperman","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2014.04.003_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1620\/tjem.205.297","article-title":"Aquisition, mobilization and utilization of cellular iron and heme: endless findings and growing evidence of tight regulation","volume":"205","author":"Taketani","year":"2005","journal-title":"Tohoku J Exp Med"},{"issue":"12","key":"10.1016\/j.hoc.2014.04.003_bib21","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/sj.emboj.7601735","article-title":"Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin","volume":"26","author":"De Domenico","year":"2007","journal-title":"EMBO J"},{"issue":"6","key":"10.1016\/j.hoc.2014.04.003_bib22","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s10534-011-9476-8","article-title":"Glutathione: a key component of the cytoplasmic labile iron pool","volume":"24","author":"Hider","year":"2011","journal-title":"Biometals"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2014.04.003_bib23","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.3109\/03630260903346593","article-title":"Blood transfusion: quality and safety issues in thalassemia, basic requirements and new trends","volume":"33","author":"Porter","year":"2009","journal-title":"Hemoglobin"},{"issue":"3","key":"10.1016\/j.hoc.2014.04.003_bib24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2141.1995.tb08351.x","article-title":"Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major","volume":"89","author":"Cazzola","year":"1995","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.hoc.2014.04.003_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1537-2995.1997.37297203514.x","article-title":"A\u00a0moderate transfusion regimen may reduce iron loading in beta- thalassemia major without producing excessive expansion of erythropoiesis","volume":"37","author":"Cazzola","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.hoc.2014.04.003_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/bmj.2.5909.16","article-title":"Long term chelation therapy in thalassaemia: effect on liver iron concentration, liver histology and clinical progress","volume":"2","author":"Barry","year":"1974","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajh.10313","article-title":"Iron in sickle cell disease: a review why less is better","volume":"73","author":"Koduri","year":"2003","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.hoc.2014.04.003_bib28","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1182\/blood.V28.5.708.708","article-title":"Urinary iron excretion and renal metabolism of hemoglobin in hemolytic diseases","volume":"28","author":"Sears","year":"1966","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib29","first-page":"17","article-title":"Urinary iron in patients with sickle cell anamia","volume":"86","author":"Washington","year":"1975","journal-title":"J\u00a0Lab Clin Med"},{"issue":"5864","key":"10.1016\/j.hoc.2014.04.003_bib30","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.1151133","article-title":"A\u00a0heme export protein is required for red blood cell differentiation and iron homeostasis","volume":"319","author":"Keel","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.hoc.2014.04.003_bib31","unstructured":"Porter JB, Walter PB, Neumayr LD, et al. Mechanisms of plasma NTBI generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients. Br J Haematol, in press."},{"issue":"26","key":"10.1016\/j.hoc.2014.04.003_bib32","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1056\/NEJMoa050460","article-title":"Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease","volume":"353","author":"Adams","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2014.04.003_bib33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2141.2011.08720.x","article-title":"Long-term safety and efficacy of deferasirox (exjade\u00ae) in transfused patients with sickle cell disease treated for up to 5 years","volume":"154","author":"Vichinsky","year":"2011","journal-title":"Br J Haematol"},{"issue":"2\u20133","key":"10.1016\/j.hoc.2014.04.003_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000205875","article-title":"Transfusion and exchange transfusion in sickle cell anaemias, with particular reference to iron metabolism","volume":"78","author":"Porter","year":"1987","journal-title":"Acta Haematol"},{"key":"10.1016\/j.hoc.2014.04.003_bib35","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1182\/blood.V83.4.1136.1136","article-title":"Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease","volume":"83","author":"Kim","year":"1994","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2014.04.003_bib36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-0609.2007.00985.x","article-title":"Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study","volume":"80","author":"Porter","year":"2008","journal-title":"Eur J Haematol"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2014.04.003_bib37","first-page":"7","volume":"19","author":"Porter","year":"2005","journal-title":"Pathophysiology of iron overload. Hematol Oncol Clin North Am"},{"issue":"4","key":"10.1016\/j.hoc.2014.04.003_bib38","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/cr.2009.19","article-title":"Oxidative modification of caspase-9 facilitates its activation via disulfide-mediated interaction with Apaf-1","volume":"19","author":"Zuo","year":"2009","journal-title":"Cell Res"},{"issue":"3","key":"10.1016\/j.hoc.2014.04.003_bib39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ccr.2004.09.003","article-title":"Nuclear factor-kappaB: the enemy within","volume":"6","author":"Aggarwal","year":"2004","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/bbrc.1995.1469","article-title":"Relationship between free iron level and rat liver mitochondrial dysfunction in experimental dietary iron overload","volume":"209","author":"Ceccarelli","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"issue":"6\u00a0Pt 1","key":"10.1016\/j.hoc.2014.04.003_bib41","doi-asserted-by":"crossref","first-page":"C1354","DOI":"10.1152\/ajpcell.1995.268.6.C1354","article-title":"Transport of iron and other transition metals into cells as revealed by a fluorescent probe","volume":"268","author":"Breuer","year":"1995","journal-title":"Am J Physiol"},{"issue":"34","key":"10.1016\/j.hoc.2014.04.003_bib42","doi-asserted-by":"crossref","first-page":"20291","DOI":"10.1074\/jbc.271.34.20291","article-title":"The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase","volume":"271","author":"Cooper","year":"1996","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1042\/bst0250075","article-title":"Ribonucleotide reductase, lipoxygenase and the intracellular low- molecular-weight iron pool","volume":"25","author":"Cooper","year":"1997","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.canlet.2008.02.038","article-title":"Redox signaling and cancer: the role of \u201clabile\u201d iron","volume":"266","author":"Galaris","year":"2008","journal-title":"Cancer Lett"},{"issue":"10","key":"10.1016\/j.hoc.2014.04.003_bib45","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1182\/blood.V94.10.3593.422k26_3593_3603","article-title":"H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties","volume":"94","author":"Epsztejn","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2014.04.003_bib46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000203949","article-title":"Use of chelators in preventing hydroxyl radical damage: adult respiratory distress syndrome as an experimental model for the treatment of oxygen-radical-mediated tissue damage","volume":"95","author":"Marx","year":"1996","journal-title":"Acta Haematol"},{"key":"10.1016\/j.hoc.2014.04.003_bib47","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0026-895X(25)14117-5","article-title":"Microsomal lipid peroxidation. 1. Characterisation of the role of iron and NADPH","volume":"17","author":"Kornbrust","year":"1980","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.hoc.2014.04.003_bib48","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1172\/JCI110787","article-title":"Hepatic lipid peroxidation in\u00a0vivo in rats with chronic iron overload","volume":"71","author":"Bacon","year":"1983","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.hoc.2014.04.003_bib49","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1172\/JCI115423","article-title":"Alterations in the structure, physicochemical properties, and pH of hepatocyte lysosomes in experimental iron overload","volume":"88","author":"Myers","year":"1991","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib50","first-page":"127","article-title":"Iron loading of cultured cardiac myocytes modifies sarcolemmal structure and increases lysosomal fragility","volume":"121","author":"Link","year":"1993","journal-title":"J\u00a0Lab Clin Med"},{"issue":"5","key":"10.1016\/j.hoc.2014.04.003_bib51","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0022-2143(98)90148-2","article-title":"Mitochondrial respiratory enzymes are a major target of iron toxicity in rat heart cells","volume":"131","author":"Link","year":"1998","journal-title":"J\u00a0Lab Clin Med"},{"issue":"2","key":"10.1016\/j.hoc.2014.04.003_bib52","first-page":"367","article-title":"Hepatocyte apoptosis in hepatic iron overload diseases","volume":"12","author":"Zhao","year":"1997","journal-title":"Histol Histopathol"},{"issue":"4","key":"10.1016\/j.hoc.2014.04.003_bib53","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00024382-200014040-00007","article-title":"Injection of iron compounds followed by induction of the stress response causes tissue injury and apoptosis","volume":"14","author":"Jacob","year":"2000","journal-title":"Shock"},{"issue":"6","key":"10.1016\/j.hoc.2014.04.003_bib54","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI114934","article-title":"Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload","volume":"86","author":"Houglum","year":"1990","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.hoc.2014.04.003_bib55","first-page":"16957","article-title":"Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increased procollagen (I) gene expression in human fat storing cells","volume":"264","author":"Parola","year":"1993","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.hoc.2014.04.003_bib56","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1172\/JCI118055","article-title":"Cell specific expression of transforming growth factor-\u00df in the rat liver","volume":"96","author":"Bissell","year":"1995","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.hoc.2014.04.003_bib57","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2141.1989.tb04328.x","article-title":"Lipid peroxidation of human granulocytes (PMN) and monocytes by iron complexes","volume":"72","author":"Hoepelman","year":"1989","journal-title":"Br J Haematol"},{"issue":"21","key":"10.1016\/j.hoc.2014.04.003_bib58","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1182\/blood-2009-10-245001","article-title":"Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation","volume":"115","author":"Hod","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2014.04.003_bib59","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3324\/haematol.10842","article-title":"Liver iron concentrations and urinary hepcidin in beta-thalassemia","volume":"92","author":"Origa","year":"2007","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.hoc.2014.04.003_bib60","first-page":"809","article-title":"The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major","volume":"91","author":"Kattamis","year":"2006","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.hoc.2014.04.003_bib61","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/oxfordjournals.bmb.a071374","article-title":"Management of thalassaemia major","volume":"32","author":"Modell","year":"1976","journal-title":"Br Med Bull"},{"issue":"8","key":"10.1016\/j.hoc.2014.04.003_bib62","first-page":"13","article-title":"Thalassemia in Britain and Australia","volume":"12","author":"Modell","year":"1976","journal-title":"Birth Defects Orig Artic Ser"},{"issue":"14","key":"10.1016\/j.hoc.2014.04.003_bib63","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.110.007641","article-title":"On T2* magnetic resonance and cardiac iron","volume":"123","author":"Carpenter","year":"2011","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.hoc.2014.04.003_bib64","first-page":"1187","article-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","volume":"89","author":"Borgna-Pignatti","year":"2004","journal-title":"Haematologica"},{"issue":"21","key":"10.1016\/j.hoc.2014.04.003_bib65","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1182\/blood.V116.21.1011.1011","article-title":"A\u00a0decade follow-up of a thalassemia major (TM) cohort monitored by cardiac magnetic resonance imaging (CMR):\u00a0significant reduction in patients with cardiac iron and in total mortality","volume":"116","author":"Thomas","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib66","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1365-2141.2003.04732.x","article-title":"Hepatocellular carcinoma in the thalassaemia syndromes","volume":"124","author":"Borgna-Pignatti","year":"2004","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.hoc.2014.04.003_bib67","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM199409013310902","article-title":"Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major","volume":"331","author":"Brittenham","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hoc.2014.04.003_bib68","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0002-9343(71)90240-3","article-title":"Iron in the heart. Etiology and clinical significance","volume":"51","author":"Buja","year":"1971","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.hoc.2014.04.003_bib69","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF01141308","article-title":"Organ-specific crystalline structures of ferritin cores in beta-thalassemia\/hemoglobin E","volume":"4","author":"St Pierre","year":"1991","journal-title":"Biol Met"},{"issue":"23","key":"10.1016\/j.hoc.2014.04.003_bib70","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","article-title":"Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload","volume":"22","author":"Anderson","year":"2001","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.hoc.2014.04.003_bib71","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05202.x","article-title":"Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance","volume":"127","author":"Anderson","year":"2004","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.hoc.2014.04.003_bib72","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2008-04-148767","article-title":"Longitudinal analysis of heart and liver iron in thalassemia major","volume":"112","author":"Noetzli","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib73","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-0609.2010.01449.x","article-title":"Patterns of liver iron accumulation in patients with sickle cell disease and thalassemia with iron overload","volume":"85","author":"Hankins","year":"2010","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.hoc.2014.04.003_bib74","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200008033430503","article-title":"Hepatic iron concentration and total body iron stores in thalassemia major","volume":"343","author":"Angelucci","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.hoc.2014.04.003_bib75","first-page":"1232","article-title":"Transfusion-related chronic liver disease in sickle cell anemia","volume":"86","author":"Comer","year":"1991","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib76","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1182\/blood.V96.1.76","article-title":"Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy","volume":"96","author":"Harmatz","year":"2000","journal-title":"Blood"},{"issue":"1 Suppl 1","key":"10.1016\/j.hoc.2014.04.003_bib77","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0037-1963(01)90060-5","article-title":"Progression of iron overload in sickle cell disease","volume":"38","author":"Olivieri","year":"2001","journal-title":"Semin Hematol"},{"issue":"5","key":"10.1016\/j.hoc.2014.04.003_bib78","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/MPH.0b013e3181a1c143","article-title":"Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy","volume":"31","author":"Brown","year":"2009","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"11","key":"10.1016\/j.hoc.2014.04.003_bib79","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ajh.20685","article-title":"Circumstances of death in adult sickle cell disease patients","volume":"81","author":"Darbari","year":"2006","journal-title":"Am J Hematol"},{"issue":"Suppl 12","key":"10.1016\/j.hoc.2014.04.003_bib80","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/ajh.21100","article-title":"Concepts and goals in the management of transfusional iron overload","volume":"82","author":"Porter","year":"2007","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.hoc.2014.04.003_bib81","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/jmri.21018","article-title":"Myocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathy","volume":"26","author":"Westwood","year":"2007","journal-title":"J\u00a0Magn Reson Imaging"},{"issue":"5","key":"10.1016\/j.hoc.2014.04.003_bib82","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1182\/blood-2003-06-1919","article-title":"Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease","volume":"103","author":"Wood","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib83","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ajh.20402","article-title":"Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia","volume":"80","author":"Vichinsky","year":"2005","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.hoc.2014.04.003_bib84","doi-asserted-by":"crossref","first-page":"446a","DOI":"10.1182\/blood.V108.11.1553.1553","article-title":"MRI evidence of cardiac iron accumulation in myelodysplasia and unusual anemias","volume":"108","author":"Glanville","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2014.04.003_bib85","first-page":"E96","article-title":"Iron distribution assessed by MRI in sickle cell disease, thalassemia and diamond blackfan anemia (MSCIO pilot study)","volume":"88","author":"Wang","year":"2013","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib86","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10534-010-9391-4","article-title":"Does high serum iron level induce low bone mass in sickle cell anemia?","volume":"24","author":"Sadat-Ali","year":"2011","journal-title":"Biometals"},{"issue":"3","key":"10.1016\/j.hoc.2014.04.003_bib87","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/jmri.21490","article-title":"Magnetic resonance detection of kidney iron deposition in sickle cell disease: a marker of chronic hemolysis","volume":"28","author":"Schein","year":"2008","journal-title":"J\u00a0Magn Reson Imaging"},{"issue":"5","key":"10.1016\/j.hoc.2014.04.003_bib88","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2141.2012.09093.x","article-title":"Renal iron load in sickle cell disease is influenced by severity of haemolysis","volume":"157","author":"Vasavda","year":"2012","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2014.04.003_bib89","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1365-2141.1999.01745.x","article-title":"Determinants of iron status and bilirubin levels in congenital dyserythropoietic anaemia type I","volume":"107","author":"Wickramasinghe","year":"1999","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.hoc.2014.04.003_bib90","first-page":"825","article-title":"Detection of early cardiac dysfunction in patients with transfusion-dependent aplastic anemia and chronic iron overload in childhood. Stress-velocity relation as a sensitive index by echocardiography","volume":"37","author":"Ohnuma","year":"1996","journal-title":"Rinsho Ketsueki"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib91","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3904\/kjim.2009.24.1.33","article-title":"Cost analysis of iron-related complications in a single institute","volume":"24","author":"Kim","year":"2009","journal-title":"Korean J Intern Med"},{"issue":"6","key":"10.1016\/j.hoc.2014.04.003_bib92","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1600-0609.2007.00842.x","article-title":"Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity\/mortality","volume":"78","author":"Takatoku","year":"2007","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib93","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12185-008-0117-0","article-title":"Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea","volume":"88","author":"Lee","year":"2008","journal-title":"Int J Hematol"},{"issue":"8","key":"10.1016\/j.hoc.2014.04.003_bib94","doi-asserted-by":"crossref","first-page":"e23109","DOI":"10.1371\/journal.pone.0023109","article-title":"Hepcidin levels and their determinants in different types of myelodysplastic syndromes","volume":"6","author":"Santini","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.hoc.2014.04.003_bib95","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1182\/blood-2002-09-2754","article-title":"Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool","volume":"101","author":"Jensen","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2014.04.003_bib96","first-page":"464","article-title":"Secondary hemochromatosis in polytransfused patients with myelodysplastic syndromes","volume":"30","author":"Jaeger","year":"1992","journal-title":"Beitr Infusionsther"},{"issue":"21","key":"10.1016\/j.hoc.2014.04.003_bib97","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1182\/blood.V118.21.2775.2775","article-title":"Transfusion-dependency is the most important prognostic factor for survival in 1000 newly diagnosed MDS patients with low- and intermediate-1 risk MDS in the European leukemianet MDS registry","volume":"118","author":"de Swart","year":"2011","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.hoc.2014.04.003_bib98","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1200\/JCO.2009.25.2395","article-title":"Incidence and clinical complications of myelodysplastic syndromes among United States medicare beneficiaries","volume":"28","author":"Goldberg","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib99","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/hon.902","article-title":"Improved survival in patients with myelodysplastic syndrome receiving iron chelation therapy","volume":"28","author":"Leitch","year":"2010","journal-title":"Hematological Oncology"},{"issue":"7","key":"10.1016\/j.hoc.2014.04.003_bib100","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.leukres.2009.12.004","article-title":"Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM","volume":"34","author":"Rose","year":"2010","journal-title":"Leuk Res"},{"issue":"22","key":"10.1016\/j.hoc.2014.04.003_bib101","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood.V114.22.1747.1747","article-title":"Matched-pair analysis of 186 MDS patients receiving iron chelation therapy or transfusion therapy only","volume":"114","author":"Fox","year":"2009","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.hoc.2014.04.003_bib102","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1182\/blood.V118.21.2776.2776","article-title":"Impact of iron chelation therapy on overall survival and AML transformation in lower risk MDS patients treated at the Moffitt Cancer Center","volume":"118","author":"Komrokji","year":"2011","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.hoc.2014.04.003_bib103","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3324\/haematol.2011.048546","article-title":"Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes","volume":"97","author":"Gattermann","year":"2012","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.hoc.2014.04.003_bib104","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1182\/blood-2004-09-3468","article-title":"Redox active plasma iron in C282Y\/C282Y hemochromatosis","volume":"105","author":"Le Lan","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2014.04.003_bib105","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0168-8278(00)80240-8","article-title":"Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method","volume":"32","author":"Loreal","year":"2000","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.hoc.2014.04.003_bib106","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nm920","article-title":"L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy","volume":"9","author":"Oudit","year":"2003","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.hoc.2014.04.003_bib107","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00109-005-0029-x","article-title":"Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy","volume":"84","author":"Oudit","year":"2006","journal-title":"J\u00a0Mol Med"},{"issue":"4","key":"10.1016\/j.hoc.2014.04.003_bib108","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1172\/JCI112125","article-title":"Efficient clearance of non-transferrin-bound iron by rat liver. Implications for hepatic iron loading in iron overload states","volume":"76","author":"Brissot","year":"1985","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.hoc.2014.04.003_bib109","first-page":"243","article-title":"Iron loading modifies the fatty acid composition of cultured rat myocardial cells and liposomal vesicles: effect of ascorbate and alpha-tocopherol on myocardial lipid peroxidation","volume":"114","author":"Link","year":"1989","journal-title":"J\u00a0Lab Clin Med"},{"issue":"37","key":"10.1016\/j.hoc.2014.04.003_bib110","doi-asserted-by":"crossref","first-page":"13612","DOI":"10.1073\/pnas.0606424103","article-title":"Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells","volume":"103","author":"Liuzzi","year":"2006","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.hoc.2014.04.003_bib111","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1042\/cs0680463","article-title":"Low molecular weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis","volume":"68","author":"Gutteridge","year":"1985","journal-title":"Clin Sci"},{"issue":"6","key":"10.1016\/j.hoc.2014.04.003_bib112","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/10715769900300491","article-title":"Blood antioxidant status and urinary levels of catecholamine metabolites in beta-thalassemia","volume":"30","author":"De Luca","year":"1999","journal-title":"Free Radic Res"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib113","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ajh.21317","article-title":"High nontransferrin bound iron levels and heart disease in thalassemia major","volume":"84","author":"Piga","year":"2009","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.hoc.2014.04.003_bib114","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1016\/S0021-9258(18)83758-9","article-title":"Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy","volume":"264","author":"Grootveld","year":"1989","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00775-007-0297-8","article-title":"Nature of non-transferrin-bound iron: studies on iron citrate complexes and thalassemic sera","volume":"13","author":"Evans","year":"2008","journal-title":"J\u00a0Biol Inorg Chem"},{"issue":"2","key":"10.1016\/j.hoc.2014.04.003_bib116","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trsl.2010.05.002","article-title":"Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone","volume":"156","author":"Evans","year":"2010","journal-title":"Transl Res"},{"issue":"6","key":"10.1016\/j.hoc.2014.04.003_bib117","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3324\/haematol.2011.056317","article-title":"Timed non-transferrin bound iron determinations probe the origin of chelatable iron pools during deferiprone regimens and predict chelation response","volume":"97","author":"Aydinok","year":"2012","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.hoc.2014.04.003_bib118","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bcmd.2012.10.006","article-title":"Combined chelation therapy with deferasirox and deferoxamine in thalassemia","volume":"50","author":"Lal","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.hoc.2014.04.003_bib119","first-page":"468a","article-title":"Discordance in MRI assessment of iron distribution and plasma NTBI between transfusionally iron loaded adults with sickle cell and thalassaemia syndromes","volume":"100","author":"Shah","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2014.04.003_bib120","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2141.2006.06277.x","article-title":"Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease","volume":"135","author":"Walter","year":"2006","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib121","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0609.2009.01342.x","article-title":"Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients","volume":"84","author":"Koren","year":"2010","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2014.04.003_bib122","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-0609.2009.01355.x","article-title":"No evidence for myocardial iron overload and free iron species in multitransfused patients with sickle\/beta-thalassaemia","volume":"84","author":"Ghoti","year":"2010","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.hoc.2014.04.003_bib123","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2141.2009.07810.x","article-title":"Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia","volume":"146","author":"Taher","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2014.04.003_bib124","unstructured":"Porter J, Cappellini CM, Kattamis A, et\u00a0al. Relationships between plasma non-transferrin-bound iron and markers of iron overload, anaemia and ineffective erythropoiesis in non-transfusion-dependent thalassaemia syndromes. Haematologica 2011;96:228. [abstract: #0536]."},{"issue":"5","key":"10.1016\/j.hoc.2014.04.003_bib125","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood-2004-02-0630","article-title":"Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron-overloaded beta-thalassemia\/HbE patients treated with an oral chelator","volume":"104","author":"Pootrakul","year":"2004","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2014.04.003_bib126","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3324\/haematol.12484","article-title":"No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia","volume":"93","author":"Origa","year":"2008","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.hoc.2014.04.003_bib127","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-0609.2011.01660.x","article-title":"Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias","volume":"87","author":"Porter","year":"2011","journal-title":"Eur J Haematol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858814000458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858814000458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:59:47Z","timestamp":1760183987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858814000458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":127,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0889858814000458"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2014.04.003","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Pathophysiology of Transfusional Iron Overload","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2014.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}